Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery

Pediatric Cardiology

Volumn 27, Issue 2, 2006, Pages 209-216

  Mir, T S ^a   Haun, C ^a   Lilje, C ^a   Laer S ^a   Weil, J ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Brain natriuretic peptide; Children; Natriuretic peptides; Pediatric surgery

Indexed keywords

CATECHOLAMINE; LACTIC ACID; N TERMINAL BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; TROPONIN T; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFANT; INTENSIVE CARE; LACTATE BLOOD LEVEL; MALE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL;

CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; LACTIC ACID; MALE; NATRIURETIC PEPTIDE, BRAIN; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TROPONIN;

EID: 33645127694     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1152-8     Document Type: Article

References (25)

1. Ationu A, Singer DRJ, Smith A, et al. (1993) Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27:1538-1541
2. Berendes E, Schmidt C, Van Aken H, et al. (2004) A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 98:11-19
3. Clerico A, Emdin M (2004) Diagnostic accurancy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50:33-50
4. Costello JM, Backer CL, Checcia PA, et al. (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25:347-353
5. Cowie MR, Mendez GF (2002) BNP and congestive heart failure. Prog Card Vasc 44:293-321
6. Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25:336-340
7. Georges A, Forestier F, Valli N, et al. (2004) Changes in type B natriuretic peptide concentrations during cardiac valve replacement. Eur J Cardio Thorac Surg 25:941-945
8. Hjortdal VE, Stenbog EV, Ravn HB (2000) Neurohumoral activation late after cavopulmonary activation. Heart 83:439-443
9. Hutfless R, Kazanegra R, Madani M, et al. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873-1879
10. Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875-878
11. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 25:341-346
12. Levin E, Gardner D, Samson W (1998) Natriuretic peptides. N Engl J Med 339:321-327
13. Maisel A (2001) B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Failure 7:183-193
14. Maisel A, Krishnaswamy P, Nowak RM, et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167
15. McDonagh TA, Cunningham AD, Morrison CE, et al. (2001) Left ventricular dysfunction, natriuertic peptides, and mortality in an urban population. Heart 86:21-26
16. Mir TS, Falkenberg J, Friedrich B, et al. (2005) Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young 15:396-401
17. Mir TS, Flato M, Falkenberg J, et al. (2005) Plasma concentrations of N-terminal-pro brain natriuretic peptide in healthy children, adolescents and young adults: effect of age and gender. Pediatr Cardiol 17, DOI: 10.1007/s00246-005-1022-y
18. Mir TS, Laux R, Hellwege HH, et al. (2003) Plasma N-terminal pro-atrial-natriuretic peptide and plasma N-terminal pro-brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112:896-899
19. Mir TS, Marohn S, Läer S, et al. (2002) Plasma concentrations of N-terminal-pro brain natriuretic peptide in children from neonatal period to adulthood and in children with congestive heart failure. Pediatrics 110:1-6
20. Muta H, Ishii M, Maeno Y, et al. (2002) Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Pediatr 91:649-652
21. Piper SN, Kumle B, Roehm KD, et al. (2003) Influence of cardiopulmonary bypass on the natriuretic peptides ANP and BNP. Anästhesiol Intensivmed Notfallmed Schmerzther 38:463-469
22. Sagnella A (2001) Measurement and importance of plasma brain natriuretic peptide and related peptides. Ann Clin Biochem 38:83-93
23. Talwar S, Siebenhofer A, Williams B, Ng LL (2000) Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal pro BNP. Heart 83:278-282
24. Troughton RW, Frampton CM, Yandle TG, et al. (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126-1130
25. Winter WE, Elin RJ (2004) The role and assessment of ventricular peptides in heart failure. Clin Lab Med 24:235-274